Literature DB >> 10775584

Posttranscriptional inhibition of class I major histocompatibility complex presentation on hepatocytes and lymphoid cells in chronic woodchuck hepatitis virus infection.

T I Michalak1, P D Hodgson, N D Churchill.   

Abstract

Woodchuck hepatitis virus (WHV), similar to human hepatitis B virus, causes acute liver inflammation that can progress to chronic hepatitis and hepatocellular carcinoma. WHV also invades cells of the host lymphatic system, where it persists for life. We report here that acute and chronic hepadnavirus hepatitis is characterized by a profound difference in the expression of class I major histocompatibility complex (MHC) molecules on the surface of infected hepatocytes and, notably, lymphoid cells. While acute WHV infection is accompanied by the enhanced hepatocyte surface presentation of class I MHC antigen and upregulated transcription of the relevant hepatic genes, inhibition of class I antigen display on liver cells is a uniform hallmark of chronic WHV infection. This inhibition in chronic hepatitis occurs despite augmented (as in acute infection) expression of hepatic genes for class I MHC heavy chain, beta(2)-microglobulin, and transporters associated with antigen processing (TAP1 and TAP2). Further, the class I antigen inhibition is not related to the histological severity of hepatocellular injury, the extent of lymphocytic infiltrations, the level of intrahepatic gamma interferon induction, or the hepatic WHV load. Importantly, the antigen expression is also inhibited on organ lymphoid cells of chronically infected hosts. The results obtained in this study demonstrate that the defective presentation of class I MHC molecules on cells supporting persistent WHV replication is due to viral posttranscriptional interference. This event may diminish the susceptibility of infected hepatocytes to virus-specific T-cell-mediated elimination, hinder virus clearance, and deregulate the class I MHC-dependent functions of the host immune system. This multifarious effect could be critical for perpetuation of liver damage and evasion of the antiviral immunological surveillance in chronic infection and therefore could be supportive of hepadnavirus persistence.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10775584      PMCID: PMC111969          DOI: 10.1128/jvi.74.10.4483-4494.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

Review 1.  Major histocompatibility complex class I antigens and the control of viral infections by natural killer cells.

Authors:  R R Brutkiewicz; R M Welsh
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

2.  Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice.

Authors:  D Kägi; B Ledermann; K Bürki; P Seiler; B Odermatt; K J Olsen; E R Podack; R M Zinkernagel; H Hengartner
Journal:  Nature       Date:  1994-05-05       Impact factor: 49.962

3.  Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes.

Authors:  L G Guidotti; T Ishikawa; M V Hobbs; B Matzke; R Schreiber; F V Chisari
Journal:  Immunity       Date:  1996-01       Impact factor: 31.745

4.  Getting the inside out: the transporter associated with antigen processing (TAP) and the presentation of viral antigen.

Authors:  A Hill; H Ploegh
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

5.  Molecular species of hepadnavirus core and envelope polypeptides in hepatocyte plasma membrane of woodchucks with acute and chronic viral hepatitis.

Authors:  T I Michalak; B Lin
Journal:  Hepatology       Date:  1994-08       Impact factor: 17.425

Review 6.  Hepatitis B virus immunopathogenesis.

Authors:  F V Chisari; C Ferrari
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

7.  Detection of hepatitis B and woodchuck hepatitis viral DNA in plasma and mononuclear cells from heparinized blood by the polymerase chain reaction.

Authors:  I U Pardoe; T I Michalak
Journal:  J Virol Methods       Date:  1995-02       Impact factor: 2.014

8.  Identification of woodchuck class I MHC antigens using monoclonal antibodies.

Authors:  T I Michalak; N D Churchill; D Codner; S Drover; W H Marshall
Journal:  Tissue Antigens       Date:  1995-05

9.  Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.

Authors:  S T Ju; D J Panka; H Cui; R Ettinger; M el-Khatib; D H Sherr; B Z Stanger; A Marshak-Rothstein
Journal:  Nature       Date:  1995-02-02       Impact factor: 49.962

10.  The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis.

Authors:  B Rehermann; P Fowler; J Sidney; J Person; A Redeker; M Brown; B Moss; A Sette; F V Chisari
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

View more
  29 in total

1.  Innate and acquired immunity intersect in a global view of the acute-phase response.

Authors:  Joo-Yeon Yoo; Stephen Desiderio
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-22       Impact factor: 11.205

2.  Hepatitis C virus infection of human T lymphocytes is mediated by CD5.

Authors:  Mohammed A Sarhan; Tram N Q Pham; Annie Y Chen; Tomasz I Michalak
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

3.  Detection of T lymphocyte subsets and mIL-2R on surface of PBMC in patients with hepatitis B.

Authors:  Ke-Xia Wang; Jiang-Long Peng; Xue-Feng Wang; Ye Tian; Jian Wang; Chao-Pin Li
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

Review 4.  The Woodchuck, a Nonprimate Model for Immunopathogenesis and Therapeutic Immunomodulation in Chronic Hepatitis B Virus Infection.

Authors:  Michael Roggendorf; Anna D Kosinska; Jia Liu; Mengji Lu
Journal:  Cold Spring Harb Perspect Med       Date:  2015-10-28       Impact factor: 6.915

5.  Inhibition by woodchuck hepatitis virus of class I major histocompatibility complex presentation on hepatocytes is mediated by virus envelope pre-S2 protein and can be reversed by treatment with gamma interferon.

Authors:  Jinguo Wang; Tomasz I Michalak
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

6.  A substituted tetrahydro-tetrazolo-pyrimidine is a specific and novel inhibitor of hepatitis B virus surface antigen secretion.

Authors:  Anne Marie Dougherty; Haitao Guo; Gael Westby; Yuanjie Liu; Ender Simsek; Ju-Tao Guo; Anand Mehta; Pamela Norton; Baohua Gu; Timothy Block; Andrea Cuconati
Journal:  Antimicrob Agents Chemother       Date:  2007-09-17       Impact factor: 5.191

7.  Bicistronic woodchuck hepatitis virus core and gamma interferon DNA vaccine can protect from hepatitis but does not elicit sterilizing antiviral immunity.

Authors:  Jinguo Wang; Shashi A Gujar; Lucyna Cova; Tomasz I Michalak
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

8.  Helper-dependent adenoviral vector-mediated delivery of woodchuck-specific genes for alpha interferon (IFN-alpha) and IFN-gamma: IFN-alpha but not IFN-gamma reduces woodchuck hepatitis virus replication in chronic infection in vivo.

Authors:  Melanie Fiedler; Florian Rödicker; Valentina Salucci; Mengji Lu; Luigi Aurisicchio; Uta Dahmen; Li Jun; Olaf Dirsch; Brigitte M Pützer; Fabio Palombo; Michael Roggendorf
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Molecular mechanisms of HBeAg in persistent HBV infection.

Authors:  Li-Min Chen; Xue-Gong Fan; Jing Ma; Bo He; Yong-Fang Jiang
Journal:  Hepatol Int       Date:  2016-05-18       Impact factor: 6.047

10.  Effect of viral load on T-lymphocyte failure in patients with chronic hepatitis B.

Authors:  Jing You; Hutcha Sriplung; Alan Geater; Virasakdi Chongsuvivatwong; Lin Zhuang; Hong-Ying Chen; Lan Yu; Bao-Zhang Tang; Jun-Hua Huang
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.